Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OBSERVATIONAL, REAL WORLD STUDY OF INFLECTRA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD) IN THE UNITED STATES AND CANADA

NCT03801928 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT03801928
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03801928 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OBSERVATIONAL, REAL WORLD STUDY OF INFLECTRA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD) IN THE UNITED STATES AND CANADA
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
February 23, 2018
Completion date
February 7, 2020
Enrollment
118 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease (cd), inflammatory bowel disease (ibd), ulcerative colitis (uc)